|
1
|
Giabicani E, Pham A, Brioude F, Mitanchez
D and Netchine I: Diagnosis and management of postnatal fetal
growth restriction. Best Pract Res Clin Endocrinol Metab.
32:523–534. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu J, Wang XF, Wang Y, Wang HW and Liu Y:
The incidence rate, high-risk factors, and short- and long-term
adverse outcomes of fetal growth restriction: A report from
Mainland China. Medicine (Baltimore). 93:e2102014. View Article : Google Scholar
|
|
3
|
Longo S, Bollani L, Decembrino L, Di
Comite A, Angelini M and Stronati M: Short-term and long-term
sequelae in intrauterine growth retardation (IUGR). J Matern Fetal
Neonatal Med. 26:222–225. 2013. View Article : Google Scholar
|
|
4
|
Verschuren MT, Morton JS, Abdalvand A,
Mansour Y, Rueda-Clausen CF, Compston CA, Luyckx V and Davidge ST:
The effect of hypoxia-induced intrauterine growth restriction on
renal artery function. J Dev Orig Health Dis. 3:333–341. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iruretagoyena JI, Davis W, Bird C, Olsen
J, Radue R, Teo Broman A, Kendziorski C, Splinter BonDurant S,
Golos T, Bird I and Shah D: Differential changes in gene expression
in human brain during late first trimester and early second
trimester of pregnancy. Prenat Diagn. 34:431–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Samuelsen GB, Pakkenberg B, Bogdanović N,
Gundersen HJ, Larsen JF, Graem N and Laursen H: Severe cell
reduction in the future brain cortex in human growth-restricted
fetuses and infants. Am J Obstet Gynecol. 197:56.e1–e7. 2007.
View Article : Google Scholar
|
|
7
|
Tatli M, Guzel A, Kizil G, Kavak V, Yavuz
M and Kizil M: Comparison of the effects of maternal protein
malnutrition and intrauterine growth restriction on redox state of
central nervous system in offspring rats. Brain Res. 1156:21–30.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu J, Liu L and Chen H: Antenatal taurine
supplementation for improving brain ultrastructure in fetal rats
with intrauterine growth restriction. Neuroscience. 181:265–270.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cohen E, Wong FY, Wallace EM, Mockler JC,
Odoi A, Hollis S, Horne RSC and Yiallourou SR: EEG power spectrum
maturation in preterm fetal growth restricted infants. Brain Res.
1678:180–186. 2018. View Article : Google Scholar
|
|
10
|
Fu LC, Lv Y, Zhong Y, He Q, Liu X and Du
LZ: Tyrosine phosphorylation of Kv1.5 is upregulated in
intrauterine growth retardation rats with exaggerated pulmonary
hypertension. Braz J Med Biol Res. 50:e62372017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baschat AA: Neurodevelopment following
fetal growth restriction and its relationship with antepartum
parameters of placental dysfunction. Ultrasound Obstet Gynecol.
37:501–514. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nardozza LM, Caetano AC, Zamarian AC,
Mazzola JB, Silva CP, Marçal VM, Lobo TF, Peixoto AB and Araujo
Júnior E: Fetal growth restriction: Current knowledge. Arch Gynecol
Obstet. 295:1061–1077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Albu AR, Horhoianu IA, Dumitrascu MC and
Horhoianu V: Growth assessment in diagnosis of fetal growth
restriction. Review. J Med Life. 7:150–154. 2014.PubMed/NCBI
|
|
14
|
Metges CC, Görs S, Lang IS, Hammon HM,
Brüssow KP, Weitzel JM, Nürnberg G, Rehfeldt C and Otten W: Low and
high dietary protein: Carbohydrate ratios during pregnancy affect
materno-fetal glucose metabolism in pigs. J Nutr. 144:155–163.
2014. View Article : Google Scholar
|
|
15
|
Li S, Guan H, Qian Z, Sun Y, Gao C, Li G,
Yang Y, Piao F and Hu S: Taurine inhibits 2,5-hexanedione-induced
oxidative stress and mitochondria-dependent apoptosis in PC12
cells. Ind Health. 55:108–118. 2017. View Article : Google Scholar :
|
|
16
|
Ripps H and Shen W: Review: Taurine: A
'very essential' amino acid. Mol Vis. 18:2673–2686. 2012.
|
|
17
|
Liu J, Liu L, Wang XF, Teng HY and Yang N:
Antenatal supplementation of taurine for protection of fetal rat
brain with intrauterine growth restriction from injury by reducing
neuronal apoptosis. Neuropediatrics. 43:258–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu J, Wang X, Liu Y, Yang N, Xu J and Ren
X: Antenatal taurine reduces cerebral cell apoptosis in fetal rats
with intrauterine growth restriction. Neural Regen Res.
8:2190–2197. 2013.
|
|
19
|
Jansson N, Pettersson J, Haafiz A,
Ericsson A, Palmberg I, Tranberg M, Ganapathy V, Powell TL and
Jansson T: Down-regulation of placental transport of amino acids
precedes the development of intrauterine growth restriction in rats
fed a low protein diet. J Physiol. 576:935–946. 2006.PubMed/NCBI
|
|
20
|
Zhou X, Wang P, Zhang YJ, Xu JJ, Zhang LM,
Zhu L, Xu LP, Liu XM and Su PP: Comparative proteomic analysis of
melanosis coli with colon cancer. Oncol Rep. 36:3700–3706. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan-Fang T, Zhi-Heng L, Li-Xiao X, Fang F,
Jun L, Gang L, Lan C, Na-Na W, Xiao-Juan D, Li-Chao S, et al:
Molecular mechanism of the cell death induced by the histone
deacetylase pan inhibitor LBH589 (Panobinostat) in Wilms tumor
cells. PLoS One. 10:e01265662015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Cruz-Lemini M, Crispi F, Van Mieghem T,
Pedraza D, Cruz-Martínez R, Acosta-Rojas R, Figueras F,
Parra-Cordero M, Deprest J and Gratacós E: Risk of perinatal death
in early-onset intrauterine growth restriction according to
gestational age and cardiovascular doppler indices: A multicenter
study. Fetal Diagn Ther. 32:116–122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Romo A, Carceller R and Tobajas J:
Intrauterine growth retardation (IUGR): Epidemiology and etiology.
Pediatr Endocrinol Rev. 6(Suppl 3): S332–S336. 2009.
|
|
25
|
Figueras F, Cruz-Martinez R, Sanz-Cortes
M, Arranz A, Illa M, Botet F, Costas-Moragas C and Gratacos E:
Neurobehavioral outcomes in preterm, growth-restricted infants with
and without prenatal advanced signs of brain-sparing. Ultrasound
Obstet Gynecol. 38:288–294. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bassan H, Stolar O, Geva R, Eshel R,
Fattal-Valevski A, Leitner Y, Waron M, Jaffa A and Harel S:
Intrauterine growth-restricted neonates born at term or preterm:
How different? Pediatr Neurol. 44:122–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park SY, Jung WJ, Kang JS, Kim CM, Park G
and Choi YW: Neuroprotective effects of α-iso-cubebene against
glutamate-induced damage in the HT22 hippocampal neuronal cell
line. Int J Mol Med. 35:525–532. 2015. View Article : Google Scholar
|
|
28
|
Kubo T, Hata K, Yamaguchi A and Yamashita
T: Rho-ROCK inhibitors as emerging strategies to promote nerve
regeneration. Curr Pharm Des. 13:2493–2499. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Turck CW, Webhofer C, Nussbaumer M,
Teplytska L, Chen A, Maccarrone G and Filiou MD: Stable isotope
metabolic labeling suggests differential turnover of the DPYSL
protein family. Proteomics Clin Appl. 10:1269–1272. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tan F, Wahdan-Alaswad R, Yan S, Thiele CJ
and Li Z: Dihydropyrimidinase-like protein 3 expression is
negatively regulated by MYCN and associated with clinical outcome
in neuroblastoma. Cancer Sci. 104:1586–1592. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arimura N and Kaibuchi K: Neuronal
polarity: From extracellular signals to intracellular mechanisms.
Nat Rev Neurosci. 8:194–205. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Inatome R, Tsujimura T, Hitomi T, Mitsui
N, Hermann P, Kuroda S, Yamamura H and Yanagi S: Identification of
CRAM, a novel unc-33 gene family protein that associates with CRMP3
and protein-tyrosine kinase(s) in the developing rat brain. J Biol
Chem. 275:27291–27302. 2000.PubMed/NCBI
|
|
33
|
Eaton BA, Fetter RD and Davis GW: Dynactin
is necessary for synapse stabilization. Neuron. 34:729–741. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Puls I, Jonnakuty C, LaMonte BH, Holzbaur
EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, et al:
Mutant dynactin in motor neuron disease. Nat Genet. 33:455–456.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lorenzo DN, Badea A, Davis J, Hostettler
J, He J, Zhong G, Zhuang X and Bennett V: A
PIK3C3-Ankyrin-B-Dynactin pathway promotes axonal growth and
multiorganelle transport. J Cell Biol. 207:735–752. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hempstead BL, Birge RB, Fajardo JE,
Glassman R, Mahadeo D, Kraemer R and Hanafusa H: Expression of the
v-crk oncogene product in PC12 cells results in rapid
differentiation by both nerve growth factor- and epidermal growth
factor-dependent pathways. Mol Cell Biol. 14:1964–1971. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Matsuda M, Hashimoto Y, Muroya K, Hasegawa
H, Kurata T, Tanaka S, Nakamura S and Hattori S: CRK protein binds
to two guanine nucleotide-releasing proteins for the Ras family and
modulates nerve growth factor-induced activation of Ras in PC12
cells. Mol Cell Biol. 14:5495–5500. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Birge RB, Fajardo JE, Mayer BJ and
Hanafusa H: Tyrosine-phosphorylated epidermal growth factor
receptor and cellular p130 provide high affinity binding substrates
to analyze Crk-phosphotyrosine-dependent interactions in vitro. J
Biol Chem. 267:10588–10595. 1992.PubMed/NCBI
|
|
39
|
Kowara R, Moraleja KL and Chakravarthy B:
Involvement of nitric oxide synthase and ROS-mediated activation of
L-type voltage-gated Ca2+ channels in NMDA-induced
DPYSL3 degradation. Brain Res. 1119:40–49. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kowara R, Kristoffer L and Chakravarthy B:
Evidence that NMDA-induced DPYSL3 truncation involves ROS-mediated
activation of nitric oxide synthase and L-type voltage-gated
Ca2+ channels. Brain Res. 1119:40–49. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim YS, Kim EK, Jeon NJ, Ryu BI, Hwang JW,
Choi EJ, Moon SH, Jeon BT and Park PJ: Antioxidant effect of
taurine-rich paroctopus dofleini extracts through inhibiting ROS
production against LPS-induced oxidative stress in vitro and in
vivo model. Adv Exp Med Biol. 975(Pt 2): 1165–1177. 2017.
View Article : Google Scholar : PubMed/NCBI
|
